Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Solvay Expands Diphenols Product Range and Capacity and Extends Footprint in India to Develop Food-Grade Antioxidants - The Pharma Times | Pharma & Health Care News Portal

Solvay Expands Diphenols Product Range and Capacity and Extends Footprint in India to Develop Food-Grade Antioxidants

India, July 18, 2016;  Solvay, worldwide leader in Diphenols and derivatives, has recently announced a capacity extension project for hydroquinone (HQ), catechol (PC) and para-methoxyphenol (MEHQ or PMP) at its Zhenjiang site, China.

From this innovative and environmentally friendly new capacity, Solvay will continue to serve the market growth in India and Asia. This expansion is scheduled to be operational in 2018.

From this hydroquinone and catechol competitive platform, Solvay intends to grow in butyl hydroxyl anisole (BHA) and tertio butyl hydroquinone (TBHQ) Diphenol derivatives used as food and feed antioxidants” revealed Jacques Guglielmi, Asia VP & General Manager at Solvay Aroma Performance.

For this purpose, Solvay has already invested and successfully started up a new high quality BHA production in France since November 2015 and will start a new technology TBHQ production in India in July 2016.

Based on its strong and sustainable worldwide Diphenols & derivatives expertise, Solvay also recently started a new Vanillin plant in China, fully FSSC 22000 food certified along the integrated production from Catechol to Vanillin. “Solvay is determined to reinforce its position in India by bringing the highest level of food safety for the benefit of Indian consumers,” affirmed Mukesh Malhotra, Solvay’s India Country Manager.

India is a strategic market where Solvay will continue to consider every next growth opportunity.

Follow us on twitter @SolvayGroup

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

1 day ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

3 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

1 week ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

2 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago